| Inventor | Institute |
|---|---|
| Bart Vanhaesebroeck | University College London |
| SKU: | 161068 |
|---|---|
| Product description: | The PI3K signalling pathway plays a central role in tumour progression, and its inhibition has been a key focus for therapeutic applications and advances in cancer research. UCL-TRO-1938, specifically stimulates the activity of the PI3Kalpha isoform – an effector of growth factor signalling. 1938 selectively activates PI3Kalpha with minimal effects on other PI3Kalpha isoforms and kinases tested. 1938 allosterically activates PI3Kalpha through a mechanism distinct from physiological activators and induces transient activation of PI3Kalpha signalling in rodent and human cells. |
| Alternate name: | 1938 |
| Additional notes: | Use in cells at 1-10 uM (see Gong et al. Nature). Do not use at concentrations above 10 uM for cell-based assays longer than 24h. |
| Molecular weight: | 456.59 |
| Chemical name: | 1-(7-((2-((4-(4-ethylpiperazin-1-yl)phenyl)amino )pyridin-4-yl)amino )indolin-1-yl)ethan- 1-one |
| Selectivity: | No activity on all other PI3K and PIKK isoforms tested – no relevant inhibition of kinases as determined by a kinase profiling screen (ThermoFischer). |
| Cat. #: | 161068 |
|---|---|
| Unit size: | 5mg |
| Research Fields: | Cell signaling and signal transduction |
| Application: | Signal transduction in a broad range of mammalian cells (human/rat/mouse) |
| Purpose: | Tool compound to probe for PI3Ka activity in cells and tissues |
| Primary citation: | Gong GQ et al. A small-molecule PI3Kα activator for cardioprotection and neuroregeneration. 2023. Nature. 618(7963):159-168. PMID: 37225977. |
| Primary target: | PI3Kalpha – PIK3CA – phosphoinositide 3-kinase alpha – Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha |
|---|
| Format: | Dry |
|---|---|
| Storage conditions: | Powder can be stored at room temperature – store aliquots of 10 mM stock dissoved in DMSO at -20C for shorter time (3 month) longer storage is recommended at -80C |
| Shipping conditions: | 5mg dry powder shipped at room temperature |
| Solubility: | Soluble in DMSO, Max conc. 10 mM |
| References: |
Gong GQ et al. A small-molecule PI3Kα activator for cardioprotection and neuroregeneration. 2023. Nature. 618(7963):159-168. PMID: 37225977 Kingwell K. PI3K activator taps route to regeneration. Nat Rev Drug Discov. 2023 Jul 22(7):537. PMID: 37291416. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.